0001671584-25-000001.txt : 20250418 0001671584-25-000001.hdr.sgml : 20250418 20250418122213 ACCESSION NUMBER: 0001671584-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20250418 DATE AS OF CHANGE: 20250418 EFFECTIVENESS DATE: 20250418 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aptevo Therapeutics Inc. CENTRAL INDEX KEY: 0001671584 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 811567056 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-544060 FILM NUMBER: 25849666 BUSINESS ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 206-838-0500 MAIL ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 D 1 primary_doc.xml X0708 D LIVE 0001671584 Aptevo Therapeutics Inc. 2401 4TH AVE. SUITE 1050 SEATTLE WA WASHINGTON 98121 206-838-0500 DELAWARE None None Corporation true Marvin L White 2401 4th Avenue Suite 1050 Seattle WA WASHINGTON 98121 Executive Officer Director Pharmaceuticals Decline to Disclose 06c false 2025-04-03 false true true false 0 2100004 2100004 0 false 11 0 0 0 false Aptevo Therapeutics Inc. Marvin L. White Marvin L. White President and Chief Executive Officer 2025-04-18